Precision Optics

POCI · NASDAQ

$4.26−$0.01 (−0.23%)TodayMarket closed ·
Prev close $4.27

About POCI

Precision Optics Corp. engages in the design, development, manufacture, and selling of optical instruments. The company is headquartered in Gardner, Massachusetts and currently employs 90 full-time employees. The Company’s segments include medical devices and advanced defense/aerospace products. Its optical and imaging technology, custom designs, manufacturing capabilities, and engineering and development capabilities have generated traditional endoscopes and endocouplers, digital imaging endoscopes using complementary metal-oxide-semiconductor (CMOS) sensor technology, some designed and manufactured for single-use, as well as other custom imaging and illumination products for our customers’ use in minimally invasive surgical procedures. The company designs and manufactures precision endoscopes and microprecision lenses, assemblies and complete medical devices to meet the surgical community’s demand for imaging systems for minimally invasive surgery. Its technologies serve defense / aerospace markets, including applications supporting satellite network communications.

Employees
90
Headquarters
Gardner, Massachusetts
Listed
Jan 16, 1992
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
poci.com

POCI key statistics

Market cap
46.74M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
46.95K
Volume
12.40K
Open price
$4.28
High today
$4.34
Low today
$4.25
52 Week high
$6.15
52 Week low
$3.55

Precision Optics (POCI) at a glance

Precision Optics (POCI) last traded at $4.26, with a market cap of 46.74M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $4.25 and $4.34. The current price is 0.2% above the day's low and 1.8% below its high.

Volume so far is 12.40K shares, below the average of 46.95K shares a day.

Over the past year Precision Optics has ranged from $3.55 to $6.15, and now sits 27% of the way up that range.

Precision Optics met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q3 FY26 it reported -$0.01 per share against an estimate of $0.00.

POCI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 83.7% on average.

  1. Q1 FY25: reported -$0.21 per share against an estimate of $0.00
  2. Q2 FY25: reported -$0.15 per share against an estimate of $0.00
  3. Q3 FY25: reported -$0.30 per share against an estimate of $0.00
  4. Q4 FY25: reported -$0.18 per share against an estimate of $0.00
  5. Q1 FY26: reported -$0.21 per share against an estimate of $0.00
  6. Q4 FY26: reported -$0.01 per share against an estimate of -$0.0612
  7. Q2 FY26: reported -$0.23 per share against an estimate of $0.00
  8. Q3 FY26: reported -$0.01 per share against an estimate of $0.00

POCI news

  • Precision Optics Corp Q4 2026 Earnings Call: Complete Transcript

  • Rishabh Mishra

    Stock Market Today: S&P 500, Dow, Nasdaq Futures Gain As Trump Clears NVDA's H200 Sales To China— Cisco Systems, Doximity In Focus (UPDATED)

  • Mohd Haider

    Precision Optics Corporation (POCI) Stock Surges Over 23% Overnight: Why Is It Moving?

  • Full Transcript: Precision Optics Corp Q3 2026 Earnings Call

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releaseGlobe Newswire

    Precision Optics Customer Receives FDA 510(k) Clearance; Accelerates Production Order for POC Single-Use Endoscope Imaging Assembly

Similar companies

Companies in the same industry as Precision Optics

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.